Press Releases - 2025-12-02

Date	Title	Company
02-Dec-2025	GE HealthCare introduces advanced imaging solutions powered by NVIDIA technology to support timely diagnoses and streamlined clinical workflows	Businesswire
02-Dec-2025	The Most Comfortable LifeVest® WCD Ever: ZOLL Completes Full U.S. Launch of Next Generation Garment	Businesswire
02-Dec-2025	Ostro Named to Inc.’s 2025 Best in Business List for Best AI Implementation	Businesswire
02-Dec-2025	Latin America Cement Industry Report 2025: Portland, Blended, Specialty, and Green Cement Size & Forecast by Value and Volume Across 80+ Market Segments 2020-2029 - ResearchAndMarkets.com	Businesswire
02-Dec-2025	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
02-Dec-2025	Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting	Businesswire
02-Dec-2025	Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System	Businesswire
02-Dec-2025	Aera Therapeutics to Present Preclinical Data on AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases, at the 67th American Society of Hematology (ASH) Annual Meeting	Businesswire
02-Dec-2025	FrieslandCampina Strengthens Its Global Protein Position With Acquisition of Wisconsin Whey Protein	Businesswire
02-Dec-2025	Tenpoint Therapeutics, Ltd. to Participate in Upcoming Investor Conference	Businesswire
02-Dec-2025	Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors	Businesswire
02-Dec-2025	Strand Therapeutics Appoints Jeb Keiper to Board of Directors	Businesswire
02-Dec-2025	Latus Bio Announces IND Clearance of LTS-101 for CLN2 Disease and Receipt of Fast Track, Orphan Drug, and Rare Pediatric Disease Designations	Businesswire
02-Dec-2025	IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform	Businesswire
02-Dec-2025	QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting	Businesswire
02-Dec-2025	enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness	Businesswire
02-Dec-2025	President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution	ACCESS Newswire
02-Dec-2025	ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions	Businesswire
02-Dec-2025	Valo Health Appoints Rita Kale as Chief Financial Officer	Businesswire
02-Dec-2025	PumasAI’s AskPumas Surpasses 15,000 Questions Answered as Global Use of AI Tools in Drug Development Accelerates	PumasAI